What question did this study set out to answer?

To evaluate clinical risk factors, particularly patient age and drug dosage, associated with agranulocytosis induced by antithyroid medications.

January 1, 1983Annals of Internal Medicine

Agranulocytosis Associated with Antithyroid Drugs

View Full Paper

Ask AI

Bookmark

Authors

DCDavid S. CooperCincinnati Children's Hospital Medical Center DGDavid GoldminzColumbia University PLP. W. LadensonJohns Hopkins University

Discussion

Member takes

Implication

Retrospective comparative study finds older age and higher methimazole doses increase agranulocytosis risk in hyperthyroid patients, suggesting low-dose regimens enhance safety.

Key Points

To evaluate clinical risk factors, particularly patient age and drug dosage, associated with agranulocytosis induced by antithyroid medications.
Reviewed records of 14 patients with antithyroid drug-related agranulocytosis from two Boston hospitals (Group 1) and 36 published case reports (Group 2).
Compared clinical characteristics of affected patients against a control group of 50 hyperthyroid patients treated with antithyroid drugs without hematologic complications (Group 3).
Patients with agranulocytosis were significantly older than controls (Group 1: 50.6 ± 16.0 years, p < 0.001; Group 2: 46.3 ± 18.7 years, p < 0.02 vs Group 3: 35.7 ± 13.7 years), with age >40 years conferring a 6.4-fold increased relative risk (p < 0.001).
Methimazole doses were significantly higher in agranulocytosis cases than controls (Group 1: 43.8 ± 9.9 mg/d, p < 0.001; Group 2: 40.7 ± 15.7 mg/d, p < 0.02 vs Group 3: 29.5 ± 10.4 mg/d), with doses >40 mg/d associated with an 8.6-fold higher risk (p < 0.01) and no cases observed at doses <30 mg/d.
Mean propylthiouracil doses did not differ significantly between agranulocytosis patients and controls.

Cite This Study

Cooper et al. (1983) studied this question.

synapsesocial.com/papers/6a86fa04540b033b21bf023d https://doi.org/10.7326/0003-4819-98-1-26

View Full Paper

Ask AI

Bookmark

Implication

Retrospective comparative study finds older age and higher methimazole doses increase agranulocytosis risk in hyperthyroid patients, suggesting low-dose regimens enhance safety.

Agranulocytosis Associated with Antithyroid Drugs

Discussion

Member takes

Implication

Key Points

Cite This Study

Agranulocytosis Associated with Antithyroid Drugs

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider